How Effective is Taking Venetoclax After a BTK Inhibitor or Chemotherapy? 

If you take venetoclax after a BTK inhibitor, you might wonder how well a venetoclax will work for you. 

Studies have shown the following data: 

• You have an 84.1% chance that your CLL signs and symptoms will be reduced by venetoclax. 
• The average amount of time you can expect venetoclax to keep you in remission since you start showing signs of response to the treatment is 3.6 years. 

If you have received chemotherapy as your first treatment, followed by a covalent BTK inhibitor, studies show the following: 

• You have a 78.3% chance that your CLL signs and symptoms will be reduced by venetoclax. 
• The average amount of time you can expect venetoclax to keep you in remission since you start showing signs of response to the treatment is 3.7 years. 

Despite previously being treated with a BTK inhibitor or chemotherapy, patients who receive venetoclax have high response rates. If you are interested in taking venetoclax after a BTK inhibitor or chemotherapy, reach out to your CLL specialist to evaluate this treatment option.